FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Prodded to Improve Surrogate Endpoint Transparency

A Federation of American Scientists online paper says FDA, other federal research agencies, and Congress should take steps to increase surrogate endpo...

latest-news-card-1
Human Drugs

Biotech Leaders Support Access to Mifepristone

A letter from dozens of biotechnology industry executives and investors urges FDA commissioner Marty Makary to reject efforts to restrict access to th...

latest-news-card-1
Human Drugs

Support for Biosimilar Legislation

Forty health advocacy groups led by the Association for Accessible Medicines voice their support for legislation to eliminate the distinction between ...

latest-news-card-1
FDA General

FDA Urged to Expand Real-World Data Use

A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety and effectiveness of ...

latest-news-card-1
Medical Devices

Multiple Insightra Medical Violations Cited

FDA warns Clarksville, TN-based Insightra Medical about multiple violations in its production of intra-aortic balloon pump catheter kits with specific...

latest-news-card-1
Medical Devices

Expanded Parkinsons Use OKd for Insightec Device

FDA approves an expanded indication for Insightecs Exablate Neuro platform for staged bilateral pallidothalamic tractotomy treatment in patients livin...

latest-news-card-1
Human Drugs

CGMP Violations at Exela Pharma Sciences

FDA warns Lenoir, NC-based Exela Pharma Sciences about CGMP violations in its work as a drug manufacturing outsourcing facility.

latest-news-card-1
Human Drugs

Taiho Reports Unfavorable DMD Drug Data

Taiho Pharmaceutical reports disappointing data from its Phase 3 extension study of TAS-205 (pizuglanstat) in patients with Duchenne muscular dystroph...

latest-news-card-1
Human Drugs

FDA Drops REMS Need for ERA Meds

FDA drops REMS requirements covering embryofetal toxicity risk in endothelin receptor antagonists.

latest-news-card-1
Human Drugs

FDA Study Finds Liver Risks Associated with CBD

A new FDA clinical trial finds that cannabidiol may cause liver enzyme elevations in otherwise healthy adults raising new concerns about the safety o...